Indication

Latent early syphilis

Latent early syphilis, also termed early latent syphilis or early nonprimary nonsecondary syphilis, is an asymptomatic, systemic stage of infection caused by the spirochete bacterium *Treponema pallidum* that was acquired within the preceding 12 months. Read more about Latent early syphilis

3 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Latent early syphilis therapies.

Showing 1–3 of 3 drugs

Filter & compare in the drug finder →Opens the drug finder with Latent early syphilis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Latent early syphilis.

Latent early syphilis, also termed early latent syphilis or early nonprimary nonsecondary syphilis, is an asymptomatic, systemic stage of infection caused by the spirochete bacterium *Treponema pallidum* that was acquired within the preceding 12 months.

It affects sexually active individuals and is characterized by reactive treponemal and nontreponemal serologic tests in the absence of clinical signs or lesions typical of primary, secondary, or tertiary syphilis.

Pathophysiologically, viable spirochetes persist within host tissues while escaping overt mucocutaneous manifestations, leaving the host capable of episodic bacteremic relapses and vertical or sexual transmission.

Definitive categorization requires laboratory confirmation alongside documented seroconversion, a significant nontreponemal titer increase, unequivocal symptoms, or sexual contact with an infected partner within the prior year.

Personalize your experience

Follow Latent early syphilis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it